InnoCare Pharma Ltd. (HK:9969) has released an update.
InnoCare Pharma Limited successfully held its Annual General Meeting on June 27, 2024, with shareholders overwhelmingly passing all proposed resolutions, including the approval of the previous year’s financial statements, the 2023 Annual Report, and various mandates for share allocations and repurchases. Notably, the election and re-election of board members, as well as the authorization for the board to set director remuneration, were also approved with high percentages of votes in favor.
For further insights into HK:9969 stock, check out TipRanks’ Stock Analysis page.
